Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Bifunctional epoxide hydrolase 2 | ||
Ligand | BDBM50217474 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_444681 (CHEMBL894930) | ||
IC50 | 14±n/a nM | ||
Citation | Hwang, SH; Tsai, HJ; Liu, JY; Morisseau, C; Hammock, BD Orally bioavailable potent soluble epoxide hydrolase inhibitors. J Med Chem50:3825-40 (2007) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Bifunctional epoxide hydrolase 2 | |||
Name: | Bifunctional epoxide hydrolase 2 | ||
Synonyms: | Cytosolic epoxide hydrolase 2 | EBifunctional epoxide hydrolase 2 | EPHX2 | Epoxide hydratase | HYES_HUMAN | Lipid-phosphate phosphatase | Soluble epoxide hydrolase (sEH) | epoxide hydrolase 2, cytoplasmic | ||
Type: | Enzyme | ||
Mol. Mass.: | 62613.07 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P34913 | ||
Residue: | 555 | ||
Sequence: |
| ||
BDBM50217474 | |||
n/a | |||
Name | BDBM50217474 | ||
Synonyms: | CHEMBL395714 | trans-1-adamantan-1-yl-3-(4-hydroxycyclohexyl)urea | ||
Type | Small organic molecule | ||
Emp. Form. | C17H28N2O2 | ||
Mol. Mass. | 292.4164 | ||
SMILES | O[C@H]1CC[C@@H](CC1)NC(=O)NC12CC3CC(CC(C3)C1)C2 |wU:1.0,wD:4.7,TLB:10:11:14.13.18:16,THB:12:13:16:20.11.19,12:11:14.13.18:16,19:11:14:18.17.16,19:17:14:20.12.11,10:11:14:18.17.16,(13.98,7.12,;13.26,5.76,;14.07,4.45,;13.36,3.1,;11.81,3.04,;10.99,4.34,;11.72,5.7,;11.09,1.68,;9.56,1.62,;8.73,2.92,;8.84,.25,;7.3,.19,;6.29,-1.08,;4.88,-.52,;3.38,-.94,;4.58,.33,;4.57,1.82,;5.91,2.3,;4.87,1.07,;7.31,1.72,;5.9,-.15,)| | ||
Structure |